-
A Study to Evaluate the CAMS Relational Agent System (CAMS-RAS) for Suicide Prevention
Rochester, MN
The purpose of this study is a continuation of the Phase I feasibility study where the investigators fully met and exceeded project aims to design, build, and test the usability and acceptability of an avatar-based system, the Virtual-CAMS (V-CAMS, formerly called CAMS-RAS), for use by suicidal ED patients and medical personnel responsible for their care.
Phase II includes a formative phase, during which the investigators will continue conducting usability and acceptability tests of new features, and a summative phase to conduct a clinical trial. SBIR Phase II project aims include: (1) Complete development of V-CAMS, including readiness for electronic health ...
-
Evaluation of the Educational Tool: The Suicidal Recovery Path poster
Rochester, MN
The purpose of this study is to explore the experiences of patients with the educational tool: The Suicidal Recovery Path poster.
-
Quantitative EEG Correlates of Suicidal Behaviors in Children and Adolescents
Rochester, MN
The purpose of this study is to examine qEEG correlates of suicidal ideations and behaviors (SIBS) (screened by the Columbia-Suicide Severity Rating Scale (C-SSRS)) in hospitalized adolescents between the ages of 13-18 years as compared to age-matched healthy participants.
-
Common Mechanisms of Anti-Suicidal Drug Action
Rochester, MN
The purpose of this study is to characterize the effects of clozapine, lithium, and ketamine on mTOR signaling, glucose uptake, and overall cellular metabolic function in peripheral blood mononuclear cells (PBMCs) from suicidal psychiatric inpatients.
-
A Study To Evaluate Jaspr Application Compared To Care As Usual (CAU) In Emergency Department
Rochester, MN
The purpose of this study is to compare Jaspr to Care-as-Usual (CAU) in Emergency departments nationwide.
-
Ketamine for Depression and Suicide Risk
No Locations
Study hypothesis: Do serial low-dose ketamine infusions, followed by weekly maintenance infusions, increase the length of time depressive symptoms stay in remission and the length of time associated suicide risk is improved? Brief Summary: This open label clinical trial is intended to further clarify initial response to low-dose ketamine infusion with repeated dosing and maintenance treatment model. Primary outcomes will be reduction in depression severity and reduction of suicide risk along with duration of response.